BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 14744781)

  • 21. Matrix metalloproteinases and metastatic cancer.
    Cockett MI; Murphy G; Birch ML; O'Connell JP; Crabbe T; Millican AT; Hart IR; Docherty AJ
    Biochem Soc Symp; 1998; 63():295-313. PubMed ID: 9513731
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Matrix metalloproteinase-1 is a crucial bone metastasis factor in a human breast cancer-derived highly invasive cell line.
    Okuyama N; Matsumine A; Kosugi R; Wakabayashi H; Uchida A
    Oncol Rep; 2008 Dec; 20(6):1497-504. PubMed ID: 19020733
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Scatter factor stimulates tumor growth and tumor angiogenesis in human breast cancers in the mammary fat pads of nude mice.
    Lamszus K; Jin L; Fuchs A; Shi E; Chowdhury S; Yao Y; Polverini PJ; Laterra J; Goldberg ID; Rosen EM
    Lab Invest; 1997 Mar; 76(3):339-53. PubMed ID: 9121117
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Over-expression of tissue inhibitor of matrix metalloproteinases (TIMP1 and TIMP2) suppresses extravasation of pulmonary metastasis of a rat bladder carcinoma.
    Kawamata H; Kawai K; Kameyama S; Johnson MD; Stetler-Stevenson WG; Oyasu R
    Int J Cancer; 1995 Nov; 63(5):680-7. PubMed ID: 7591285
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selective involvement of TIMP-2 in the second activational cleavage of pro-MMP-2: refinement of the pro-MMP-2 activation mechanism.
    Lafleur MA; Tester AM; Thompson EW
    FEBS Lett; 2003 Oct; 553(3):457-63. PubMed ID: 14572669
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cancer progression by breast tumors with Pit-1-overexpression is blocked by inhibition of metalloproteinase (MMP)-13.
    Sendon-Lago J; Seoane S; Eiro N; Bermudez MA; Macia M; Garcia-Caballero T; Vizoso FJ; Perez-Fernandez R
    Breast Cancer Res; 2014 Dec; 16(6):505. PubMed ID: 25527274
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of tumor cell matrix metalloproteinase-2 by neutrophil proteinases requires expression of membrane-type 1 matrix metalloproteinase.
    Schwartz JD; Shamamian P; Monea S; Whiting D; Marcus SG; Galloway AC; Mignatti P
    Surgery; 1998 Aug; 124(2):232-8. PubMed ID: 9706143
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of MMP-2 activation potential with metastatic progression in human breast cancer cell lines independent of MMP-2 production.
    Azzam HS; Arand G; Lippman ME; Thompson EW
    J Natl Cancer Inst; 1993 Nov; 85(21):1758-64. PubMed ID: 8411260
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dominant-negative CREB inhibits tumor growth and metastasis of human melanoma cells.
    Xie S; Price JE; Luca M; Jean D; Ronai Z; Bar-Eli M
    Oncogene; 1997 Oct; 15(17):2069-75. PubMed ID: 9366524
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bioluminescent human breast cancer cell lines that permit rapid and sensitive in vivo detection of mammary tumors and multiple metastases in immune deficient mice.
    Jenkins DE; Hornig YS; Oei Y; Dusich J; Purchio T
    Breast Cancer Res; 2005; 7(4):R444-54. PubMed ID: 15987449
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of matrix metalloproteinase inhibitor batimastat on breast cancer regrowth and metastasis in athymic mice.
    Sledge GW; Qulali M; Goulet R; Bone EA; Fife R
    J Natl Cancer Inst; 1995 Oct; 87(20):1546-50. PubMed ID: 7563189
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Implication of collagen type I-induced membrane-type 1-matrix metalloproteinase expression and matrix metalloproteinase-2 activation in the metastatic progression of breast carcinoma.
    Gilles C; Polette M; Seiki M; Birembaut P; Thompson EW
    Lab Invest; 1997 May; 76(5):651-60. PubMed ID: 9166284
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of the precursor of gelatinase A/72 kDa type IV collagenase/MMP-2 in lung carcinomas correlates with the expression of membrane-type matrix metalloproteinase (MT-MMP) and with lymph node metastasis.
    Tokuraku M; Sato H; Murakami S; Okada Y; Watanabe Y; Seiki M
    Int J Cancer; 1995 Oct; 64(5):355-9. PubMed ID: 7591310
    [TBL] [Abstract][Full Text] [Related]  

  • 34. S100A4 involvement in metastasis: deregulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in osteosarcoma cells transfected with an anti-S100A4 ribozyme.
    Bjørnland K; Winberg JO; Odegaard OT; Hovig E; Loennechen T; Aasen AO; Fodstad O; Maelandsmo GM
    Cancer Res; 1999 Sep; 59(18):4702-8. PubMed ID: 10493528
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Introduction of basic fibroblast growth factor gene into mouse renal cell carcinoma cell line enhances its metastatic potential.
    Miyake H; Hara I; Yoshimura K; Eto H; Arakawa S; Wada S; Chihara K; Kamidono S
    Cancer Res; 1996 May; 56(10):2440-5. PubMed ID: 8625325
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Down-regulation of metastatic phenotype in human melanoma cells by controlled expression of anti-sense matrix metalloproteinase 9].
    Kong LL; Fang WG; You JF; Zhong HH; Zheng J
    Zhonghua Bing Li Xue Za Zhi; 2003 Apr; 32(2):137-41. PubMed ID: 12839676
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Collagen induced MMP-2 activation in human breast cancer.
    Thompson EW; Yu M; Bueno J; Jin L; Maiti SN; Palao-Marco FL; Pulyaeva H; Tamborlane JW; Tirgari R; Wapnir I
    Breast Cancer Res Treat; 1994; 31(2-3):357-70. PubMed ID: 7881112
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Widespread skeletal metastatic potential of human lung cancer revealed by green fluorescent protein expression.
    Yang M; Hasegawa S; Jiang P; Wang X; Tan Y; Chishima T; Shimada H; Moossa AR; Hoffman RM
    Cancer Res; 1998 Oct; 58(19):4217-21. PubMed ID: 9766640
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of linoleic acid on the growth and metastasis of two human breast cancer cell lines in nude mice and the invasive capacity of these cell lines in vitro.
    Rose DP; Connolly JM; Liu XH
    Cancer Res; 1994 Dec; 54(24):6557-62. PubMed ID: 7987856
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of osteolytic bone metastasis of breast cancer by combined treatment with the bisphosphonate ibandronate and tissue inhibitor of the matrix metalloproteinase-2.
    Yoneda T; Sasaki A; Dunstan C; Williams PJ; Bauss F; De Clerck YA; Mundy GR
    J Clin Invest; 1997 May; 99(10):2509-17. PubMed ID: 9153295
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.